<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0677950" disease_type="Neoplastic Process" abbrv="">Stage IV colorectal cancer</z:e> encompasses various clinical conditions </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to validate the utility of the recent AJCC <z:e sem="disease" ids="C0677950" disease_type="Neoplastic Process" abbrv="">stage IV colorectal cancer</z:e> sub-classification, and to establish a prognostic scoring system using independent factors </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: We conducted a retrospective analysis using data from the multicenter registry </plain></SENT>
<SENT sid="3" pm="."><plain>Factors affecting the curative resection and prognosis were analyzed in patients with <z:e sem="disease" ids="C0677950" disease_type="Neoplastic Process" abbrv="">stage IV colorectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Of the 60,176 patients who received surgery for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, 9,624 (16.0 %) were classified as stage IV </plain></SENT>
<SENT sid="5" pm="."><plain>The prognoses of patients with peritoneum-only <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> were superior to those of patients with a stage <z:mp ids='MP_0010560'>IVB</z:mp> (P &lt; 0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>Of the 11 independent prognostic factors identified, eight with a hazard ratio greater than 1.3 (depth of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion, regional lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, histologic grade, <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e>, lung <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, distant lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, peritoneal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, and curative resection) were used in the prognostic scoring system </plain></SENT>
<SENT sid="7" pm="."><plain>The scoring system gave one or two points for the presence of each prognosis risk factor, resulting in a total score ranging from 0 to 9 </plain></SENT>
<SENT sid="8" pm="."><plain>The 5-year overall survival rates of patients with a total score of 0-2, 3, 4, 5, and 6-9 were 50.4, 30.4, 17.7, 7.7, and 4.0 %, respectively (P &lt; 0.0001) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Although the AJCC staging for patients with <z:e sem="disease" ids="C0677950" disease_type="Neoplastic Process" abbrv="">stage IV colorectal cancer</z:e> reflected the prognosis, patients with peritoneum-only <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> should be classified as stage <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IVA</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>The prognostic scoring system using eight independent factors is useful in predicting the survival of patients with <z:e sem="disease" ids="C0677950" disease_type="Neoplastic Process" abbrv="">stage IV colorectal cancer</z:e> </plain></SENT>
</text></document>